Brookfield Renewable Announces Medium-Term Note Redemption Price Information
All amounts in U.S. dollars unless otherwise statedNOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR DISSEMINATION TO THE UNITED […]
IZEA Reports Q3 Bookings of $7.7 Million
Orlando, Oct. 11, 2019 (GLOBE NEWSWIRE) — IZEA Worldwide, Inc. (NASDAQ: IZEA), operator of IZEAx®, the premier online marketplace connecting brands […]
Teekay Corporation Announces 3.5-Year Contract for the Hummingbird Spirit FPSO
VANCOUVER, British Columbia, Oct. 11, 2019 (GLOBE NEWSWIRE) — Teekay Corporation (Teekay or the Company) (NYSE:TK) announced that it has […]
Brown & Brown, Inc. Announces the Asset Acquisition of Poole Professional Companies
DAYTONA BEACH, Fla., Oct. 11, 2019 (GLOBE NEWSWIRE) — J. Scott Penny, Chief Acquisitions Officer of Brown & Brown, Inc. […]
DryShips Inc. Announces Completion of Acquisition by SPII Holding Inc.
ATHENS, Greece, Oct. 11, 2019 (GLOBE NEWSWIRE) — DryShips Inc. (the “Company”) (NASDAQ: DRYS), a diversified owner and operator of […]
ChromaDex Statement Regarding the October 9th Order in the Central District of California Litigation
LOS ANGELES, Oct. 11, 2019 (GLOBE NEWSWIRE) — ChromaDex Corp. (NASDAQ:CDXC) issued the following statement.We would like to take this opportunity […]
Medallion Resources Closes Private Placement Total of $794,874
VANCOUVER, British Columbia, Oct. 11, 2019 (GLOBE NEWSWIRE) — Medallion Resources Ltd. (TSX-V: MDL; OTCPK: MLLOF; Frankfurt: MRDN) – “Medallion” […]
Triumph Gold Letter to Shareholders
VANCOUVER, British Columbia, Oct. 11, 2019 (GLOBE NEWSWIRE) —Dear Triumph Gold Corp. Shareholders,Following last week’s announcement of changes to our […]
ObsEva SA to Present Model-Based Analysis Supporting Clinical Use of Linzagolix at Doses Not Requiring Hormonal Add back Therapy
Once-daily oral Linzagolix doses of 75 mg and 100 mg without hormonal add-back therapy could lead to symptom relief of […]
BrainStorm’s NurOwn® Phase 3 ALS Clinical Trial Now Fully Enrolled
NEW YORK, Oct. 11, 2019 (GLOBE NEWSWIRE) — BrainStorm Cell Therapeutics, Inc. (NASDAQ: BCLI), a leading developer of adult stem […]
